Darzalex

New Multiple Myeloma Drug Can Prove More Beneficial If Administered Earlier

By Dipannita - Jun 08, 2016 03:09 PM EDT

An immunotherapy drug recently-approved for a blood cancer called multiple myeloma can help produce even better results if it is administered during the early stages of the disease. These are the findings of a new study conducted by a team of researchers from the University of Torino in Italy.

Fun Stuff

Editor's pick

Real Time Analytics